Biobank For MS And Other Demyelinating Diseases

Brief Title

Biobank For MS And Other Demyelinating Diseases

Official Title

Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases

Brief Summary

      To establish a large, longitudinal collection of high quality samples and data from subjects
      with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis
      Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis
      (ON)), and related and unrelated unaffected controls. Samples and data will be available as a
      shared resource to scientists researching the causes, sub-types, and biomarkers of MS and
      related demyelinating diseases.
    



Study Type

Observational




Condition

Multiple Sclerosis


Study Arms / Comparison Groups

 Case
Description:  

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

3226

Start Date

May 2006

Completion Date

October 2036

Primary Completion Date

October 2026

Eligibility Criteria

        Inclusion Criteria:

          -  age 18+ able to give informed consent or individuals younger than 18 with parental
             permission and able to give assent

          -  willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture

          -  experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM,
             or ON

        Exclusion Criteria:

          -  history of blood borne pathogens

          -  allogeneic bone marrow transplant

          -  clinical or radiological evidence of stroke, meningitis, or other well characterized
             diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).

          -  weight less than 37 pounds
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Benjamin Greenberg, M.D., M.H.S., , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT00445367

Organization ID

ACP-001


Responsible Party

Sponsor

Study Sponsor

Accelerated Cure Project for Multiple Sclerosis


Study Sponsor

Benjamin Greenberg, M.D., M.H.S., Principal Investigator, University of Texas


Verification Date

July 2021